Patent intelligence · US
US 8906668
Synergistic bacterial compositions and methods of production and use thereof
Synergistic bacterial compositions and methods of production and use thereof
Patent details — US 8906668
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 9, 2014
- Expiration
- Dec 4, 2034
- Applicant
- Seres Health, Inc.
- Claims
- 9
- CPC classes
- A61K, A61K35/74, A61K35/742, A61K38/13
Quick answer
US 8906668 (Synergistic bacterial compositions and methods of production and use thereof) is held by Seres Health, Inc.. Status: granted. Granted Dec 9, 2014. Expires Dec 4, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Seres Health, Inc.
- Grant date
- Expiration
- Claims
- 9
- CPC classes
- A61K, A61K35/74, A61K35/742, A61K38/13, A61K45/06, A61K9/0053
More from Seres Health, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12409197
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 12214002
Compositions and methods for treating antibiotic resistance
granted -
US 12083151
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11918612
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11730775
Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof
granted -
US 11701394
Compositions and methods for treating cholestatic disease
granted -
US 11666612
Network-based microbial compositions and methods
granted -
US 11464812
Synergistic bacterial compositions and methods of production and use thereof
granted
Frequently asked questions
What is US patent 8906668?
US 8906668 (Synergistic bacterial compositions and methods of production and use thereof) is held by Seres Health, Inc.. Status: granted. Granted Dec 9, 2014. Expires Dec 4, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8906668?
Seres Health, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 36 pharmaceutical patents for this assignee.
When does US 8906668 expire?
Our index shows an expiration date of Dec 4, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.